Sernova Biotherapeutics Inc (SVA) NPV

Sell:0.18 CADBuy:0.19 CAD0.01 CAD (2.63%)

Prices delayed by at least 15 minutes
Sell:0.18 CAD
Buy:0.19 CAD
Change:0.01 CAD (2.63%)
Prices delayed by at least 15 minutes
Sell:0.18 CAD
Buy:0.19 CAD
Change:0.01 CAD (2.63%)
Prices delayed by at least 15 minutes

Company Information

About this company

Sernova Biotherapeutics Inc. is a Canada-based clinical-stage company, which is focused on developing regenerative medicine therapeutics combining its Cell Pouch with human donor cells or stem cell-derived cell therapies to create bio-hybrid organs to treat chronic diseases. A bio-hybrid organ is comprised of non-biomaterials, such as the Cell Pouch, integrated with living tissues to restore or enhance the function of a compromised organ. This approach aims to deliver a potentially revolutionary treatment for patients with chronic diseases, initially focusing on type 1 diabetes (T1D) and thyroid disorders. Cell Pouch is a bio-hybrid organ which is surgically implanted beneath the skin of the abdomen.

Key people

Ross Haghighat
Chairman of the Board
Jonathan Rigby
President, Chief Executive Officer, Executive Director
James T. Parsons
Chief Financial Officer, Director
Philip M. Toleikis
Chief Technology Officer
Frank Shannon
Vice President - Clinical Development and Regulatory Affairs
Modestus Obochi
Chief Business Officer
Marylyn Rigby
Chief Communications Officer
David Paterson
Director
Daniel Mahony
Independent Director
Steven Sangha
Independent Director
Bertram T. von Plettenberg
Independent Director
Click to see more

Key facts

  • EPIC
    SVA
  • Location
    Canada
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • ISIN
    CA81752F1062
  • Market cap
    CA$59.13m
  • Employees
    17
  • Shares in issue
    328.48m
  • Exchange
    Toronto Stock Exchange
  • Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.